AI in Precision Medicine Market Size & Analysis for North America, Europe, APAC, South America, Middle East and Africa - US, UK, France, Germany, China – 2025-2029

AI in Precision Medicine Market Size 2025-2029

The AI in precision medicine market is projected to grow by USD 9-12 billion at a compound annual growth rate (CAGR) of 33%-36% during the forecast period. Exact values for this market can be accessed upon purchasing the report.

This rapid growth is driven by significant advancements in AI technologies, increasing investments in R&D, and the rising demand for personalized medicine. A key factor propelling market expansion is the increasing adoption of AI in oncology, cardiology, neurology, and other therapeutic applications. The market also benefits from collaborations between tech giants and healthcare providers, such as GE Healthcare’s partnership with Enlitic to enhance clinical workflows. Furthermore, AI is playing a pivotal role in disease management and predictive analytics, especially with the rising incidence of diseases like cancer and neurological disorders.

To access the full market forecast and comprehensive analysis, Buy Now

How is This Market Segmented?

The market research report provides comprehensive data on segmentation, with forecasts in USD billion for the period 2025-2029, as well as historical data for the following segments:

• Technology:
  • Deep Learning
  • Natural Language Processing (NLP)
  • Context-Aware Processing
  • Others
• Therapeutic Application:
  • Oncology
  • Cardiology
  • Neurology
  • Respiratory
  • Others
• Geography:
  • North America
    • Canada
    • US
  • APAC
    • China
    • India
    • Japan
    • South Korea
  • Europe
    • Germany
    • UK
    • France
  • South America
    • Brazil
  • Middle East and Africa

Technology Insights

The deep learning segment dominated the AI in precision medicine market, owing to advancements in AI processing power and data modeling. The NLP segment is expected to grow at the fastest rate, significantly impacting the decision-making process in healthcare. These technologies are increasingly used in applications such as personalized diagnostics, disease management, and drug discovery and development.

Therapeutic Application Insights

Oncology emerged as the dominant therapeutic application, with significant growth expected due to AI's role in accelerating cancer diagnosis and treatment. The neurology segment is anticipated to grow at the fastest rate, driven by rising cases of neurological diseases and advancements in AI-powered neuroimaging.

Regional Analysis

North America dominated the AI in precision medicine market in 2024, driven by the presence of major players like Abbott, IBM, and GE Healthcare. Europe is expected to grow significantly, fueled by increasing healthcare spending and technological advancements. The Asia Pacific region is also witnessing rapid growth, with China and India emerging as key markets for AI-driven healthcare solutions.

Market Dynamics

What are the Key Market Drivers Leading to the Rise in Adoption of AI in Precision Medicine?

The primary driver for market growth is the rising demand for personalized medicine, with AI offering more accurate, data-driven approaches to patient care. AI's integration with wearables and healthcare data analytics platforms is also improving early diagnosis and personalized treatment plans. Moreover, government initiatives in various regions are supporting the development of AI-driven healthcare solutions, further fueling market growth.

What are the Market Trends Shaping the AI in Precision Medicine Market?

A significant trend shaping the market is the increasing role of AI in oncology and neurology, particularly in accelerating diagnostic procedures and offering precision treatment plans. The growing adoption of digital health records and AI-enabled wearables is another trend, as they enable real-time health monitoring and personalized care.

What Challenges Does the AI in Precision Medicine Market Face?

Despite its growth, the market faces challenges related to data privacy and security concerns, high integration costs, and regulatory hurdles that may slow the widespread adoption of AI solutions in healthcare.

Key Companies & Market Insights

Leading companies in the AI in precision medicine market are implementing strategies such as strategic partnerships, mergers, and acquisitions to maintain a competitive edge. Prominent players in the market include:

• BioXcel Therapeutics, Inc.
• Sanofi S.A.
• NVIDIA Corp.
• Alphabet Inc.
• IBM
• Microsoft
• Intel Corp.
• AstraZeneca plc
• GE Healthcare
• Enlitic, Inc.
• AbbVie
• Cerner Corporation
• Medtronic
• Siemens Healthineers
• Philips Healthcare

These companies are continuously innovating to meet the growing demand for AI-powered solutions in personalized medicine.

Market Scope

For further information, Get Free Sample

How the Benefits of a Technavio Market Research Report Can Empower Your Business

Technavio’s reports provide a range of market insights, including:

• A detailed analysis of the market, featuring market size, growth rate, segmentation, and regional performance
• In-depth analysis of the drivers, challenges, and other dynamics that will impact the growth of the market
• Predictions about upcoming trends and changes in consumer behavior
• Detailed information on key market players, including market positioning, product offerings, and more